MARKET RADAR
SENSEX     NIFTY      
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Plethico Pharmaceuticals
BSE: 532739|NSE: PLETHICO|ISIN: INE491H01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
  
LIVE
BSE
Feb 10, 17:00
368.80
-2.4 (-0.65%)
VOLUME 34,808
LIVE
NSE
Feb 10, 17:00
367.10
-2.75 (-0.74%)
VOLUME 31,114
Announcements on Plethico Pharma

7th-Feb-2012 19:13Source: NSE

PLETHICO PHARMACEUTICALS LIMITED Disclosure under SEBI Takeover Regulations

Shashikant Patel has submitted to the Exchange a copy of Intimation under Regulation 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

24th-Jan-2012 08:21Source: NSE

Plethico Pharmaceuticals Limited

Shashikant A. Patel has submitted to the Exchange a copy of Intimation under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

16th-Jan-2012 14:37Source: BSE

Plethico Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Shashikant Patel has now submitted the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

Name of the Target Co...

16th-Jan-2012 13:10Source: NSE

Plethico Pharmaceuticals Limited

Shashikant Patel has submitted to the Exchange a copy of Revised Intimation under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

13th-Jan-2012 12:28Source: BSE

Plethico Pharma- Revised disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Shashikant Patel has now submitted the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

Name of the Target Co...

12th-Jan-2012 19:23Source: BSE

Plethico Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Shashikant Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

Name of the Target Company (TC) :...

6th-Jan-2012 11:33Source: NSE

Plethico Pharmaceuticals Limited

Plethico Pharmaceuticals Limited has informed the Exchange vide its letter dated January 06, 2012 regarding a press release dated January 04, 2012 of the Company''s wholly owned subsidiary Natrol Inc....

6th-Jan-2012 11:31Source: BSE

Plethico Pharma- Corporate Updates

Plethico Pharmaceuticals Ltd has submitted to BSE a copy of Press Release of its wholly owned subsidiary Natrol Inc., USA.

26th-Dec-2011 08:29Source: NSE

Plethico Pharmaceuticals Limited

Shashikant Patel has submitted to the Exchange a copy of Intimation under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

23rd-Dec-2011 17:47Source: BSE

Plethico Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Shashikant Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

Name of the Target Company (TC) :...

1 2 3 4 5 Next >>
Quick Links for Plethico Pharmaceuticals
Follow moneycontrol.com

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.